Difference between revisions of "Team:UCL/Safety"
Superjack15 (Talk | contribs) |
Superjack15 (Talk | contribs) |
||
Line 194: | Line 194: | ||
.bigtitle {background-image:none/* url('https://static.igem.org/mediawiki/2015/4/43/UCL_headercircle.png'); text-align: center; line-height: 2; | .bigtitle {background-image:none/* url('https://static.igem.org/mediawiki/2015/4/43/UCL_headercircle.png'); text-align: center; line-height: 2; | ||
− | background-position: top center; background-repeat: no-repeat; background-size: contain; padding: 9%; position: relative; margin-bottom: 100px; color: #22343C; | + | background-position: top center; background-repeat: no-repeat; background-size: contain; padding: 9%; position: relative; margin-bottom: 100px; color: #22343C;*/} |
.bigtitle a {color: #fff; text-decoration: none;} | .bigtitle a {color: #fff; text-decoration: none;} |
Revision as of 20:42, 18 September 2015
'
B12 riboswitch
In order to address safety issues associated with our psychobiotics, we have developed a unique B12 riboswitch-mediated
containment strategy
▼